Florida vs California Cannabis Laws

Florida is the largest medical-only cannabis market in the United States and one of the most important markets for publicly traded cannabis companies. Amendment 2 legalized medical cannabis in 2016 with 71% voter approval, and the state's medical program has grown to serve over 850,000 active patients — the largest patient registry in the nation. Annual medical cannabis sales exceed $2.5 billion.

The Florida market operates under a vertically integrated license model known as MMTC (Medical Marijuana Treatment Center) licenses. Each licensee must cultivate, process, and dispense its own cannabis products, creating high barriers to entry but also protecting established operators from new competition. The state has issued a limited number of licenses, making each one extremely valuable. A 2024 ballot measure to legalize recreational cannabis received 57% voter support but fell short of Florida's 60% supermajority threshold.

Florida is a critical market for nearly every major MSO. Trulieve, which is headquartered in the state, operates the largest dispensary network with over 130 locations. Curaleaf, Green Thumb Industries, Cresco Labs, Verano, TerrAscend, and Ayr Wellness also maintain significant Florida operations. The state's large population of 22 million, strong tourism industry, and affluent retiree demographic make it one of the most commercially attractive cannabis markets regardless of its medical-only status.

California is the largest legal cannabis market in the world, generating over $5 billion in annual licensed sales. The state has a storied history with cannabis, becoming the first in the nation to legalize medical use through Proposition 215 (the Compassionate Use Act) in 1996. Recreational legalization followed with Proposition 64 in 2016, and adult-use sales began on January 1, 2018.

Despite its enormous size, California's cannabis market faces significant challenges. A massive illicit market — estimated at two to three times the size of the legal market — continues to undercut licensed operators. The state's regulatory framework is complex, with the Department of Cannabis Control overseeing state licenses while individual cities and counties retain the authority to permit or ban cannabis businesses. As of 2025, the majority of California's 482 cities still do not allow retail cannabis sales, limiting legal access.

The state eliminated its cultivation tax in 2023 to ease the burden on growers, but the 15% excise tax on retail sales remains, along with local taxes that can push the combined effective tax rate above 30% in some jurisdictions. Major MSOs including Curaleaf, Trulieve, Cresco Labs, and TerrAscend maintain California operations, though the market is also home to hundreds of independent operators. The sheer scale and brand-building potential of California make it a strategic priority despite its competitive difficulties.